Skip to content
Screener

Avantor AVTR Cash & Equivalents

Cash & Equivalents at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.06B-11.7%
Danaher logo
DanaherDHR
$4.35B+47.0%
Agilent Technologies logo
Agilent TechnologiesA
$1.81B+21.5%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$435.8M-14.5%
Future Fuel logo
Future FuelFF
$22.37M-77.0%
Ascent Industries Co. logo
Ascent Industries Co.ACNT
$47.82M+235%

Other financials

Income statement

See full
Revenue$1.7B+0.5%
Gross profit$537.0M-3.1%
Operating income$121.8M-5.4%
Net income$38.1M-41.1%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Total debt$3.7B-12.8%
Total equity$5.6B-10.4%
Total assets$11.6B-9.2%

Cash flow

See full
Operating cash flow$178.2M+15.4%
CapEx$37.6M+27.0%
Free cash flow$140.6M+12.7%

Valuation

See full
Market cap$9.04B+18.6%
Enterprise value$12.42B+8.9%
P/S1.4×+0.2×

Profitability

See full
Gross margin31.8%-1.4pp
Operating margin4%-5.2pp
Net margin-9.6%-19.9pp
FCF margin6.9%-1.4pp

Returns & leverage

See full
Return on equity-10.6%-22.3pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.8×

Where this comes from

Reported directly by Avantor in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Avantor’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 9:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050415
(in millions)Six months ended June 30, 2026Six months ended June 30, 2025
Proceeds received from exercise of stock options1.92.6
Shares repurchased to satisfy employee tax obligations for vested stock-based awards(3.9)(5.0)
Other(0.1)
Net cash used in financing activities(219.6)(40.5)
Effect of currency rate changes on cash and cash equivalents(5.9)21.8
Net change in cash, cash equivalents and restricted cash(58.6)187.5
Cash, cash equivalents and restricted cash, beginning of period368.3264.7
Cash, cash equivalents and restricted cash, end of period$309.7$452.2

Item 1. Financial statements

FAQ

What is Avantor's cash & equivalents?
Avantor (AVTR) reported cash & equivalents of $309.7M in Q2 2026.
How has Avantor's cash & equivalents changed year-over-year?
Avantor's cash & equivalents decreased by 31.5% year-over-year, from $452.2M to $309.7M.
What is the long-term trend for Avantor's cash & equivalents?
Over 5 years (2020 to 2025), Avantor's cash & equivalents has grown at a 5.0% compound annual growth rate (CAGR), from $289.2M to $368.3M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Avantor's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude